Truffle Capital launches new technology funds
Interviewee/Contributor
Philippe Pouletty
Organisation
Truffle Capital
Research Directory
Welcome to the Euro-Nasdaq waltz
Interviewee/ContributorWilliam EllingtonOrganisationMedNousThe role of relapse vaccines in fighting cancer
Interviewee/ContributorErik MantingOrganisationDCPrime BVRNA epigenetics is coming of age
Interviewee/ContributorOliver RauschOrganisationStorm Therapeutics LtdIon channel drug discovery and modern medicine
Interviewee/ContributorMarc RogersOrganisationMetrion Biosciences LtdForendo Pharma's new approach to endometriosis
Interviewee/ContributorMaarit MerlaOrganisationForendo Pharma LtdMedtech in an era of new technology and regulation
Interviewee/ContributorMarta SwierczynskaOrganisationSFL Regulatory Affairs & Scientific Communication GmbHMeeting the challenge of viral vector manufacture
Interviewee/ContributorGabriel FestocOrganisationPolyplus-Transfection SAHuman gene therapy - immunogenicity perspective
Interviewee/ContributorJ Fraser WrightOrganisationStanford University School of MedicineA bioethical framework for therapeutic gene editing
Interviewee/ContributorJanet LambertOrganisationAlliance for Regenerative Medicine